Products
News
Resources
Contact
Language
简体中文
繁體中文
English
日本語
한국어
Tiếng Việt
上海药明生物技术有限公司 Wuxi Biologics
{{company.company_channel.channel_name}}
Media Room
Latest
Photos
{{company.company_name_local}}
{{company.company_channel.channel_name}}
Follow :
X
Company Profile
Media Room
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.title}}
loading
The End
Network Errors Please Retry
{{selectname}}
{{showName}}
{{selectall}}
{{option}}
WuXi Biologics Congratulates OncoImmune on FDA Clearance of IND Application for Next Generation anti-CTLA-4 Antibody ONC-392
2020-01-02 08:08
WuXi Biologics Receives "Special Award to Investors in Ireland" from Asia Matters
2019-12-23 16:26
WuXi Vaccines to Build a $240 Million Manufacturing Facility in Ireland
2019-11-23 01:55
WuXi Biologics Reports Outstanding Interim Results
2019-08-19 22:09
WuXi Biologics to Expand Integrated Biologics Conjugation Solution Center to Include Commercial Manufacturing
2019-06-21 08:39
WuXi Biologics Signed Letter of Intent for Long-Term Vaccine Manufacturing Contract
2019-05-21 07:30
WuXi Biologics Commenced Construction of a 48,000 L Integrated Manufacturing Center for Innovative Biologics in Chengdu
2019-05-16 15:39
WuXi Biologics Successfully Completed First FDA Routine GMP Inspection
2019-04-17 09:14
WuXi Biologics and I-Mab Biopharma Announce Long-term Strategic Manufacturing Partnership for Five Clinical and One Commercial Programs
2019-04-16 20:00
WuXi Biologics and NBE-Therapeutics Announce Comprehensive ADC Development and Manufacturing Partnership
2019-04-09 08:36
WuXi Biologics Wins 2019 CMO Leadership Awards in All Six Core Categories
2019-04-03 20:06
WuXi Biologics Receives "Asia's Best CMO of 2018" Award from IMAPAC
2019-03-26 08:24
WuXi Biologics Receives EMA GMP Certificates
2019-03-20 08:07
WuXi Biologics Continues to Deliver Record Results
2019-03-18 22:25
WuXi Biologics Congratulates Amicus on Receiving FDA Breakthrough Therapy Designation for AT-GAA
2019-02-28 09:52
ABL Bio Expands Strategic Collaboration with WuXi Biologics and Licenses WuXiBody(TM) Platform for Novel Immune Check Point Bispecifics for $220 Million
2019-02-26 08:23
EMA Completed Pre-Approval Inspection of cGMP DS and DP Facilities for Trogarzo (TM) at WuXi Biologics
2019-02-19 14:21
EMA Completed Pre-Approval Inspection of cGMP DS and DP Facilities for Trogarzo(TM) at WuXi Biologics
2019-02-19 08:21
WuXi Biologics and Amicus Sign Exclusive Manufacturing Partnership
2019-02-12 08:04
WuXi Biologics and AC Immune to Establish an Exclusive Strategic Partnership
2018-12-19 20:16
1
4
5
6
7
8
9